|
ZNF223 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.54129999558373E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.921100E-03 |
| Normal-vs-Stage2 |
6.437400E-04 |
| Normal-vs-Stage3 |
6.95320023780255E-10 |
| Normal-vs-Stage4 |
2.14361861594625E-12 |
| Stage1-vs-Stage2 |
7.848400E-02 |
| Stage1-vs-Stage3 |
3.65239999999822E-06 |
| Stage1-vs-Stage4 |
6.26230001188333E-09 |
| Stage2-vs-Stage3 |
2.442600E-01 |
| Stage2-vs-Stage4 |
3.624500E-02 |
| Stage3-vs-Stage4 |
1.726230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.99260000008661E-08 |
| Normal-vs-AfricanAmerican |
7.681700E-03 |
| Normal-vs-Asian |
3.278200E-01 |
| Caucasian-vs-AfricanAmerican |
5.216600E-01 |
| Caucasian-vs-Asian |
4.175800E-01 |
| AfricanAmerican-vs-Asian |
6.472400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01620000192426E-08 |
| Normal-vs-Female |
2.172200E-04 |
| Male-vs-Female |
4.568300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.601990E-03 |
| Normal-vs-Age(41-60Yrs) |
3.97389999999831E-05 |
| Normal-vs-Age(61-80Yrs) |
3.11800000263318E-08 |
| Normal-vs-Age(81-100Yrs) |
4.014200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.908800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.850200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.155600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.315800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.060400E-01 |
| Normal-vs-Grade 2 |
3.277300E-03 |
| Normal-vs-Grade 3 |
2.34789999664642E-08 |
| Normal-vs-Grade 4 |
1.62614366416847E-12 |
| Grade 1-vs-Grade 2 |
4.359000E-01 |
| Grade 1-vs-Grade 3 |
5.130300E-02 |
| Grade 1-vs-Grade 4 |
3.71169999999754E-05 |
| Grade 2-vs-Grade 3 |
1.284630E-03 |
| Grade 2-vs-Grade 4 |
4.07179845396399E-11 |
| Grade 3-vs-Grade 4 |
7.8067000000015E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.137800E-02 |
| Normal-vs-ccB subtype |
3.34809957536208E-10 |
| ccA subtype-vs-ccB subtype |
1.98800000017485E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.09730000045161E-07 |
| Normal-vs-N1 |
3.58440000014504E-07 |
| N0-vs-N1 |
3.432100E-02 |
|
|
